高敏肌钙蛋白I与稳定期COPD患者全因死亡率的关联:COSYCONET研究分析
本研究基于COSYCONET多中心队列中2085例稳定期COPD患者,评估高敏肌钙蛋白I(hs-TnI)对3年全因死亡的预测价值。在校正气流受限、呼吸困难、运动能力、急性加重史及心血管危险因素和疾病后,hs-TnI仍是全因死亡的显著预测因子(连续变量HR 1.28,95%CI 1.01-1.62;≥6 ng·L-1者HR 1.63,95%CI 1.10-2.42)。
要点
- 稳定期COPD患者中hs-TnI可检测率高达96.9%,中位浓度3.8 ng·L-1。
- hs-TnI是独立于传统COPD预测指标和心血管危险因素的全因死亡预测因子。
- 远低于参考上限的hs-TnI浓度仍提供额外预后价值。
核心结论
- 在稳定期COPD患者中,hs-TnI是全因死亡的强预测因子,独立于已建立的COPD死亡预测指标及广泛心血管危险因素和 prevalent 心血管疾病。
研究设计与样本
- 多中心COSYCONET队列研究,纳入2085例各严重程度的稳定期COPD患者,随访3年,主要结局为全因死亡。
主要发现
- hs-TnI在2020例(96.9%)患者中可检测,中位浓度3.8 ng·L-1(IQR 2.5-6.6 ng·L-1),1.8%患者超过99百分位参考上限27 ng·L-1。
- Cox回归校正气流受限、呼吸困难分级、运动能力、重度急性加重史、传统心血管危险因素、eGFR、踝臂指数、NT-proBNP及 prevalent 心血管疾病后,hs-TnI连续变量(log)HR 1.28(95%CI 1.01-1.62),以6 ng·L-1为切点HR 1.63(95%CI 1.10-2.42)。
临床怎么用
- 在稳定期COPD患者的风险评估中,可考虑检测hs-TnI以识别全因死亡高风险患者,即使其浓度远低于参考上限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic obstructive pulmonary disease (COPD) is a leading cause of death with a considerable part of the population dying from cardiovascular diseases. High-sensitivity troponin I (hs-TnI) might help to better identify COPD patients at high risk of mortality. We aimed to study the predictive value of hs-TnI for all-cause mortality beyond established COPD assessments, and after consideration of relevant cardiovascular risk factors and prevalent cardiovascular diseases, in a broad population with stable COPD.Circulating hs-TnI concentrations together with a wide range of respiratory and cardiovascular markers were evaluated in 2085 patients with stable COPD across all severity stages enrolled in the multicentre COSYCONET cohort study. The primary outcome was all-cause mortality over 3 years of follow-up.Hs-TnI was detectable in 2020 (96.9%) patients. The median hs-TnI concentration was 3.8 ng·L-1 (interquartile range 2.5-6.6 ng·L-1), with levels above the 99th percentile reference limit of 27 ng·L-1 observed in 1.8% of patients. In Cox regression analyses including adjustments for airflow limitation, dyspnoea grade, exercise capacity and history of severe exacerbations, as well as traditional cardiovascular risk factors, estimated glomerular filtration rate, ankle-brachial index, N-terminal pro-brain natriuretic peptides and prevalent cardiovascular diseases, hs-TnI was a significant predictor for all-cause mortality, both as a continuous variable (hazard ratio (HR) for log hs-TnI 1.28, 95% CI 1.01-1.62) and categorised according to the cut-off of 6 ng·L-1 (HR 1.63, 95% CI 1.10-2.42).In patients with stable COPD, hs-TnI is a strong predictor of all-cause mortality beyond established COPD mortality predictors, and independent of a broad range of cardiovascular risk factors and prevalent cardiovascular diseases. Hs-TnI concentrations well below the upper reference limit provide further prognostic value for all patients with COPD when added to established risk assessments.
引用
- Waschki B, Alter P, Zeller T, et al. High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study. Eur Respir J. 2020. PMID: 31831579. doi:10.1183/13993003.01314-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。